The transition to the EU Medical Device Regulation (MDR 2017/745) has created a historic bottleneck in the European market. With only 51 designated Notified Bodies available to service the entire industry, application backlogs are growing exponentially.
For manufacturers of Class III custom-made implantable devices, the transition deadline of May 26, 2026, is a hard stop. There are no further extensions.
The Risk: Industry data indicates that up to 30% of Notified Body delays are attributed to technical documentation deficiencies. A common, yet preventable, deficiency is linguistic non-conformity—translations that are technically accurate but fail the strict layperson readability tests required by MDR Annex I, Section 23.
If your translations trigger a Non-Conformity Report (NCR), you do not just get a correction request; you go to the back of the line. In the tight timeline of 2026, you cannot afford a second round of review.
Responsive Translation doesn’t just convert text; we validate compliance. Our trouble-free methodologies are built specifically for the high-stakes demands of the MDR era.
Our specialized MDR services include:
Many legacy translations approved under the MDD are not compliant with the stricter linguistic requirements of the MDR. Don’t find out during an audit.
Q: Does the MDR require ISO 13485 for translation vendors?
A: While the MDR does not explicitly name ISO 13485 for vendors, Article 10 requires manufacturers to control their supply chain. Using an ISO 13485-certified vendor is the standard method for demonstrating this control to Notified Bodies.
Q: What are the language requirements for the SSCP?
A: The SSCP must be translated into the official languages of the Member States where the device is sold. Furthermore, the patient section must be validated for layperson readability in each of those languages.
Q: Can we use AI for MDR translations?
A: Pure AI translation poses significant risks of hallucination and non-compliance. However, AI-enhanced workflows with human-in-the-loop verification can offer efficiency while maintaining the necessary safety and defensibility.
With the May 2026 deadline fast approaching, your organization needs a risk mitigation partner that understands the high-stakes nature of medical device documentation. At Responsive Translation, we specialize in providing the accurate and HIPAA-compliant translations required to protect patient safety and ensure international regulatory success. As an ISO 13485 and ISO 9001-certified provider, we offer scalable language solutions that integrate expert validation and rigorous quality assurance to help you pass Notified Body review without delays. We have three decades of experience serving compliance-intensive industries. Don’t let linguistic non-conformity derail your market access.